down arrow

McKesson Corp.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: US58155Q1031
USD
813.80
-1.74 (-0.21%)

Dec 12

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

812.00826.00

52 Week

558.13895.58
Valuation
Technical
Day's Volume

CASH

1.01 M

Shareholding (Mar 2025)

FII

24.05%

Held by 488 FIIs

DII

41.17%

Held by 49 DIIs

Promoter

0.09%

How big is McKesson Corp.?

22-Jun-2025

As of Jun 18, McKesson Corp. has a market capitalization of $179 billion, with net sales of $359 billion and a net profit of $3.48 billion over the latest four quarters.

As of Jun 18, McKesson Corp. has a market capitalization of 179,003.16 million, classifying it as a Large Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 359,051.00 million, while the sum of net profit for the same period is 3,481.00 million.<BR><BR>As of Mar 25, the shareholder's funds are reported at -2,074.00 million, and total assets amount to 75,140.00 million.

Read More

What does McKesson Corp. do?

22-Jun-2025

McKesson Corporation is a large-cap healthcare supply chain management provider, with recent net sales of $90.8 billion and a net profit of $1.3 billion. Key financial metrics include a P/E ratio of 56.00 and a dividend yield of 21.40%.

Overview:<BR>McKesson Corporation is a healthcare supply chain management solution provider operating in the retailing industry, with a market cap classified as large cap.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 90,823 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1,306 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 179,003.16 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 56.00 <BR>Dividend Yield: 21.40% <BR>Debt Equity: 0.10 <BR>Return on Equity: -151.11% <BR>Price to Book: -86.31 <BR><BR>Contact Details:<BR>Address: 6555 State Highway 161, IRVING TX: 75039-2402 <BR>Tel: 1 972 4464800 <BR>Website: http://www.mckesson.com

Read More

Who are in the management team of McKesson Corp.?

22-Jun-2025

As of March 2022, McKesson Corp.'s management team includes Independent Chairman Edward Mueller, CEO Brian Tyler, and Independent Directors Dominic Caruso, N. Anthony Coles, Christine Jacobs, Donald Knauss, and Marie Knowles, who collectively guide the company's strategic direction and governance.

As of March 2022, the management team of McKesson Corp. includes the following individuals:<BR><BR>- Mr. Edward Mueller, who serves as the Independent Chairman of the Board.<BR>- Mr. Brian Tyler, who is the Chief Executive Officer and a Director.<BR>- Mr. Dominic Caruso, who is an Independent Director.<BR>- Dr. N. Anthony Coles, who is also an Independent Director.<BR>- Ms. Christine Jacobs, serving as an Independent Director.<BR>- Mr. Donald Knauss, who is an Independent Director.<BR>- Ms. Marie Knowles, who is another Independent Director. <BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Read More

Is McKesson Corp. overvalued or undervalued?

20-Sep-2025

As of February 2, 2021, McKesson Corp. is considered risky due to its high valuation metrics and negative financial indicators, despite strong stock performance over the past year and five years.

As of 2 February 2021, the valuation grade for McKesson Corp. moved from attractive to risky, indicating a shift in its perceived investment quality. The company appears to be overvalued, given its high P/E ratio of 56 and an EV to EBITDA ratio of 36.93, which significantly exceeds those of its peers. For comparison, Boston Scientific Corp. has a P/E of 73.71 and an EV to EBITDA of 45.38, while Cencora, Inc. shows a more reasonable P/E of 40.09 and an EV to EBITDA of 19.45.<BR><BR>Despite the overvaluation, McKesson has demonstrated strong stock performance, with a 1-year return of 34.89% compared to the S&P 500's 17.14%, and a remarkable 5-year return of 353.64% against the S&P 500's 96.61%. However, the negative price-to-book value of -84.94 and the negative return on equity suggest underlying financial challenges that could impact future performance.

Read More

Is McKesson Corp. technically bullish or bearish?

20-Sep-2025

As of July 10, 2025, McKesson Corp. shows a mildly bullish trend overall, despite mixed signals from technical indicators, with a year-to-date return of 21.09% compared to the S&P 500's 12.22%.

As of 10 July 2025, the technical trend for McKesson Corp. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, indicating mixed signals. The daily moving averages are mildly bullish, suggesting some short-term strength. However, the weekly Bollinger Bands are bearish, and the KST is mildly bearish on both weekly and monthly time frames. Dow Theory shows no trend on the weekly and mildly bearish on the monthly.<BR><BR>In terms of performance, McKesson has outperformed the S&P 500 year-to-date with a return of 21.09% compared to 12.22%, and over one year, it has returned 34.89% versus the S&P 500's 17.14%. Overall, the current stance is mildly bullish, but with caution due to the bearish indicators present in the weekly analysis.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

 
2

Risky - Negative Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 171,725 Million (Large Cap)

stock-summary
P/E

56.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

23.17%

stock-summary
Debt Equity

-2.74

stock-summary
Return on Equity

-152.50%

stock-summary
Price to Book

-87.30

Revenue and Profits:
Net Sales:
97,827 Million
(Quarterly Results - Jun 2025)
Net Profit:
831 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.39%
0%
14.39%
6 Months
11.36%
0%
11.36%
1 Year
40.48%
0%
40.48%
2 Years
76.09%
0%
76.09%
3 Years
115.43%
0%
115.43%
4 Years
249.14%
0%
249.14%
5 Years
365.93%
0%
365.93%

McKesson Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
McKesson Corp. Hits New 52-Week High of $846.43, Reflecting Strong Growth

McKesson Corp. Hits New 52-Week High of $846.43, Reflecting Strong Growth

McKesson Corp. achieved a new 52-week high of USD 846.43 on November 4, 2025, reflecting strong performance in the retail sector with a 42.35% increase over the past year. The company has a market capitalization of USD 171,725 million and a notable dividend yield of 23.17%.

Read More
McKesson Corp. Hits New 52-Week High of $846.26, Reflecting Strong Growth

McKesson Corp. Hits New 52-Week High of $846.26, Reflecting Strong Growth

McKesson Corp. achieved a new 52-week high of USD 846.26 on October 30, 2025, reflecting strong performance in the retail sector with a 39.62% increase over the past year. The company has a market capitalization of USD 171,725 million and a notable dividend yield of 23.17%.

Read More
McKesson Corp. Hits New 52-Week High at $807.75

McKesson Corp. Hits New 52-Week High at $807.75

McKesson Corp. achieved a new 52-week high of USD 807.75 on October 24, 2025, reflecting strong performance in the retail sector with a 35.58% increase over the past year. The company has a market capitalization of USD 171,725 million and a notable dividend yield of 23.17%.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.33%
EBIT Growth (5y)
6.51%
EBIT to Interest (avg)
16.14
Debt to EBITDA (avg)
0.25
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
77.54
Tax Ratio
20.14%
Dividend Payout Ratio
10.69%
Pledged Shares
0
Institutional Holding
91.74%
ROCE (avg)
377.27%
ROE (avg)
72.81%
Valuation key factors
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
-84.94
EV to EBIT
42.61
EV to EBITDA
36.93
EV to Capital Employed
-77.14
EV to Sales
0.49
PEG Ratio
16.19
Dividend Yield
21.75%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 189 Schemes (34.68%)

Foreign Institutions

Held by 488 Foreign Institutions (24.05%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 23.39% vs 6.44% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -13.44% vs -3.71% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "97,827.00",
          "val2": "79,283.00",
          "chgp": "23.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,232.00",
          "val2": "1,230.00",
          "chgp": "0.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "49.00",
          "val2": "66.00",
          "chgp": "-25.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-39.00",
          "val2": "-41.00",
          "chgp": "4.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "831.00",
          "val2": "960.00",
          "chgp": "-13.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.00%",
          "val2": "13.40%",
          "chgp": "-0.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 16.22% vs 11.65% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 10.16% vs -15.17% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "359,051.00",
          "val2": "308,951.00",
          "chgp": "16.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,008.00",
          "val2": "4,562.00",
          "chgp": "9.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "256.00",
          "val2": "243.00",
          "chgp": "5.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "99.00",
          "val2": "-51.00",
          "chgp": "294.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,481.00",
          "val2": "3,160.00",
          "chgp": "10.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.20%",
          "val2": "12.70%",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
97,827.00
79,283.00
23.39%
Operating Profit (PBDIT) excl Other Income
1,232.00
1,230.00
0.16%
Interest
49.00
66.00
-25.76%
Exceptional Items
-39.00
-41.00
4.88%
Consolidate Net Profit
831.00
960.00
-13.44%
Operating Profit Margin (Excl OI)
11.00%
13.40%
-0.24%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 23.39% vs 6.44% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -13.44% vs -3.71% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
359,051.00
308,951.00
16.22%
Operating Profit (PBDIT) excl Other Income
5,008.00
4,562.00
9.78%
Interest
256.00
243.00
5.35%
Exceptional Items
99.00
-51.00
294.12%
Consolidate Net Profit
3,481.00
3,160.00
10.16%
Operating Profit Margin (Excl OI)
12.20%
12.70%
-0.05%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 16.22% vs 11.65% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 10.16% vs -15.17% in Mar 2024

All Annual Resultsstock-summary
stock-summaryCompany CV
About McKesson Corp. stock-summary
stock-summary
McKesson Corp.
Retailing
McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.
Company Coordinates stock-summary
Company Details
6555 State Highway 161 , IRVING TX : 75039-2402
stock-summary
Tel: 1 972 4464800
stock-summary
http://www.mckesson.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."